Axcelis Technologies (ACLS) stock experienced a significant drop of 16.7% following a disappointing forecast for 2025.

Axcelis Technologies anticipates flat revenue in 2026, with growth in the memory sector expected to offset declines in power and mature markets.

Exclusive | A Nuclear-Power Startup Says It Can Rouse the Slow-Moving Industry  The Wall Street Journal

Several companies, including AtriCure, RB Global, Beta Bionics, Axcelis Technologies, and Medifast, have released highlights from their fourth-quarter earnings calls.

Axcelis Technologies, Inc. has released a summary of its fourth-quarter 2025 earnings call, detailing its financial performance.

Axcelis Technologies posted a non-GAAP EPS of $1.49, beating estimates by $0.37, and revenue of $238.33M, surpassing by $23.28M.